The effects of Boswellia serrata gum resin on the blood glucose and lipid profile of diabetic patients: A double-blind randomized placebo-controlled clinical trial
How to cite
Mehrzadi, Saeed. 2015. "The effects of Boswellia serrata gum resin on the blood glucose and lipid profile of diabetic patients: A double-blind randomized placebo-controlled clinical trial." AEA RCT Registry. AEARCTR-0000898. https://doi.org/10.1257/rct.898-1.0
Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.
* Primary investigator
Abstract
Aim:: Regarding traditional use of Boswellia serrata gum resin and known pharmacological effects of this gum in diabetes, we evaluated anti-hyperglycemic and lipid lowering effects of Boswellia serrata gum resin in type 2 diabetic patients in a double blind randomized placebo-control trial.
Methods and materials: Fifty six diabetic patients were randomly allocated to two groups who received the boswellia serrata gum resin or placebo capsule. The fasting blood sugar (FBS), glycosylated hemoglobin (HbA1c) as primary outcome measures and total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglyceride and insulin level as secondary outcome measures were measured before and 8 weeks after the intervention.
Intervention
The enrolled patients were randomly assigned to receive Boswellia serrata gum capsule (n=27) as the intervention group and placebo capsule (n=29). Patients received Boswellia serrata gum 250 mg capsules or placebo capsules twice daily after meal for 8 weeks. Consumption of conventional oral hypoglycemic agents was continued in two groups simultaneously.
Experimental design
The trial is a two-arm, double-blind randomized placebo-controlled clinical trial using a parallel design with a 1:1 allocation ratio. There was no change in methods after trial commencement.
Design details
Cited by
No citation data available for this registration yet.